(Q56786354)

English

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

No description defined

In more languages

Statements

scholarly article

0 references

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia (English)

0 references

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hyperandrogenism

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Alessandro D Genazzani

object named as

Alessandro D Genazzani

1

0 references

author name string

Chiara Lanzoni

2

0 references

Federica Ricchieri

3

0 references

Enrica Baraldi

4

0 references

Elena Casarosa

5

0 references

Valerio M Jasonni

6

0 references

language of work or name

0 references

publication date

March 2007

0 references

Gynecological Endocrinology

0 references

23

0 references

3

0 references

146-52

0 references

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Metformin treatment reduces ovarian cytochrome P-450c17alpha response to human chorionic gonadotrophin in women with insulin resistance-related polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590701214398

21 January 2018

Identifiers

10.1080/09513590701214398

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56786354&oldid=2031076094"